Clinical Evaluation of a Skin Protectant for the Management of Incontinence-Associated Dermatitis
| Autor: | Catherine T. Milne, Marie Agrell-Kann, Mary R. Brennan, Bruce P. Ekholm |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
Advanced and Specialized Nursing
medicine.medical_specialty integumentary system 030504 nursing business.industry Trauma center Intensive care unit Dermatology Additional research law.invention 030207 dermatology & venereal diseases 03 medical and health sciences Medical–Surgical Nursing 0302 clinical medicine law Medicine Open label 0305 other medical science business Normal skin Prospective cohort study Adverse effect Clinical evaluation |
| Zdroj: | Journal of Wound, Ostomy & Continence Nursing. 44:172-180 |
| ISSN: | 1071-5754 |
| DOI: | 10.1097/won.0000000000000307 |
| Popis: | Purpose The purpose of this study was to evaluate the efficacy of an investigational skin protectant product at managing severe skin breakdown associated with incontinence. Design Open-label, nonrandomized, prospective study. Subjects and setting The sample comprised 16 patients; inclusion criteria were: patients older than 18 years, cared for in the intensive care unit of a level I trauma center hospital or in long-term care facilities in the northeast region of the United States, and had incontinence-associated dermatitis (IAD). Twelve of the patients had epidermal skin loss and 4 had severe redness. Methods The investigational product is a formulation based on acrylate chemistry. The skin protectant application schedule was twice weekly for up to 3 weeks for a maximum of 6 applications during the study period. The skin was evaluated via a skin assessment instrument specifically designed for use in this study; this instrument has not undergone validation studies. The main outcome measure was changes in the instrument score over time. In addition, complete reepithelialization was recorded when observed, and pain scores (associated with IAD) were noted in participants who were able to report pain. Results The IAD score improved in 13 of 16 patients, remained unchanged in 1 patient, and deteriorated in 2 patients. The median percent improvement in the skin assessment instrument was 96% (P = .013). Four of the patients with epidermal skin loss had complete reepithelialization of the skin surface with 4 to 6 applications of the skin protectant, and 5 had substantial improvement. The 4 patients with severe red skin returned to healthy normal skin with 2 to 4 skin protectant applications. Substantial pain reduction was reported by all 9 patients who reported pain at enrollment. No adverse events associated with the skin protectant application were reported during data collection. Conclusion Results of this study suggest that an acrylate-based product, evaluated here for the first time in patients, may be effective as a protective barrier in the presence of continued incontinence. Additional research is needed to confirm these findings. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|